Related Experiment Videos
Somatosensory evoked cortical potentials indicating impaired motor development in infancy
Insights
Somatosensory evoked cortical potentials (SECPs) can predict developmental outcomes in infants. Marked alterations in SECPs, like prolonged N1 peak latencies, strongly indicate future handicaps in children.
Area of Science:
- Neuroscience
- Developmental Pediatrics
- Clinical Neurophysiology
Background:
- Infant development assessment is crucial for early intervention.
- Identifying reliable biomarkers for developmental delay is essential.
- Somatosensory evoked cortical potentials (SECPs) are used to assess neurological function.
Purpose of the Study:
- To evaluate the prognostic value of SECPs in infants with suspected developmental impairments.
- To determine if specific SECP alterations predict long-term neurological handicaps.
Main Methods:
- Somatosensory evoked cortical potentials (SECPs) were performed on 120 infants (1-10 months old).
- Infants were assessed based on history, clinical findings, and follow-up examinations after age one.
- Analysis focused on N1 peak latencies and the presence/absence of potentials.
Main Results:
- Of 73 infants with initial developmental concerns, 38 showed pathological conditions at follow-up.
- 19 infants exhibited marked SECP alterations (prolonged N1 latencies or absent potentials).
- All 19 infants with marked SECP alterations were diagnosed with handicaps post-first birthday.
Conclusions:
- Marked alterations in somatosensory evoked cortical potentials have a high prognostic value for identifying infants at risk of handicap.
- SECPs can serve as a valuable tool for early detection and prediction of developmental outcomes in infants.
Abstract:
Somatosensory evoked cortical potentials were performed on 120 infants between one and 10 months of age because impaired development was suspected on the basis of their histories or clinical findings. All but two had a follow-up examination after their first birthday. Of the 120 infants, 47 presented with only minor perinatal risks: these had normal neurological and developmental findings in infancy and at follow-up and they formed the control group. 73 infants initially had developmental delay or abnormal neurological findings: at follow-up 35 were normal and 38 had pathological conditions (16 general psychomotor retardation, 15 cerebral palsy, four degenerative and three neurometabolic diseases of the CNS). Marked prolongation of N1 peak latencies (greater than 2ms) above the two-sigma border, or absence of potentials on one or both sides, indicated handicap after their first birthday in all 19 infants showing such alterations. The author concludes that these marked alterations have a high prognostic value.